Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A S Balavoine

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Annales D'Endocrinologie|September 12, 2009
Who should benefit from diabetes cell therapy?M C Vantyghem, A S Balavoine, J Kerr-Conte, et al.
Minerva Endocrinologica|April 5, 2011
Diabetes cell therapy: a decade laterM C Vantyghem, A S Balavoine, R Caiazzo, et al.
European Journal of Endocrinology|July 15, 2011
Phenotype-genotype correlation and follow-up in adult patients with hypokalaemia of renal origin suggesting Gitelman syndromeA S Balavoine, P Bataille, P Vanhille, et al.
Diabetes & Metabolism|February 11, 2014
Treating diabetes with islet transplantation: lessons from the past decade in LilleM-C Vantyghem, F Defrance, D Quintin, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Annales D'Endocrinologie|September 12, 2009
Who should benefit from diabetes cell therapy?M C Vantyghem, A S Balavoine, J Kerr-Conte, et al.
Minerva Endocrinologica|April 5, 2011
Diabetes cell therapy: a decade laterM C Vantyghem, A S Balavoine, R Caiazzo, et al.
European Journal of Endocrinology|July 15, 2011
Phenotype-genotype correlation and follow-up in adult patients with hypokalaemia of renal origin suggesting Gitelman syndromeA S Balavoine, P Bataille, P Vanhille, et al.
Diabetes & Metabolism|February 11, 2014
Treating diabetes with islet transplantation: lessons from the past decade in LilleM-C Vantyghem, F Defrance, D Quintin, et al.
Pageof 1